Abstract:<span>A series of injectable in situ dual-crosslinking hydrogels (HA/ALG) based on oxidized sodium alginate (oxi-ALG) and hyaluronic acid modified with thiol and hydrazide (HA-SH/CDH) were prepared via hydrazone bonds and disulfide bonds. The chemical structures, morphologies, rheological properties, gelling time, swelling ratio, degradation rate and drug release behavior of hydrogels were investigated. HA/ALG hydrogels exhibited tunable gelling time, rheological properties, swelling ratio and degradation rate with varying precursor concentrations. The gelling time of HA/ALG hydrogels ranged from 157 s to 955 s, the values of yield stress of HA2/ALG2, HA3/ALG3 and HA4/ALG4 hydrogels were 1724, 4349 and 5306 Pa, and the degradation percentage of HA2/ALG2, HA3/ALG3 and HA4/ALG4 hydrogels were about 64%, 51% and 42% after incubating 35 days, respectively. Bovine serum albumin (BSA) was used as a model drug to investigate the drug controlled release properties, and the in vitro cumulative release percentage of BSA from HA2/ALG2, HA3/ALG3 and HA4/ALG4 drug-loaded hydrogels were about 79%, 72% and 69% after 20 days. The series of injectable in situ dual-crosslinking HA/ALG hydrogels could be an attractive candidate for drug delivery system, tissue engineering and regenerative medicine.<b>Graphical </b>Injectable in situ dual-crosslinking hydrogels (HA/ALG) were prepared from thiol- and hydrazide-bifunctionalized hyaluronic acid (HA-SH/CDH) and oxidized alginates (oxi-ALG). Hydrogels exhibited tunable gelling time, appropriate rheology properties, high swelling ratio, low degradation percentage and sustainable controlled release properties, signifying that they could be potentially used in the fields of drug controlled release, cell encapsulation, tissue engineering and regenerative medicine.</span>

Injectable hydrogels based on the hyaluronic acid and poly (γ-glutamic acid) for controlled protein delivery.

Biocompatible, Injectable Anionic Hydrogels Based on Poly(Oligo Ethylene Glycol Monoacrylate‐co‐Acrylic Acid) for Protein Delivery

In situ photocrosslinked hyaluronic acid and poly (γ-glutamic acid) hydrogels as injectable drug carriers for load-bearing tissue application

Construction and Characterization of a Pure Protein Hydrogel for Drug Delivery Application.

A novel injectable and in situ crosslinked hydrogel based on hyaluronic acid and α,β-polyaspartylhydrazide

Synthesis of casein-γ-polyglutamic acid hydrogels by microbial transglutaminase-mediated gelation for controlled release of drugs

Injectable Hyaluronic Acid/poly(ethylene Glycol) Hydrogels Crosslinked Via Strain-Promoted Azide-Alkyne Cycloaddition Click Reaction

Fabrication of Injectable, Porous Hyaluronic Acid Hydrogel Based on an In-Situ Bubble-Forming Hydrogel Entrapment Process

Controlled Release of Protein from Biodegradable Multi-Sensitive Injectable Poly(Ether-Urethane) Hydrogel

Injectable in situ dual-crosslinking hyaluronic acid and sodium alginate based hydrogels for drug release

Injectable All-Polysaccharide Self-Assembling Hydrogel: a Promising Scaffold for Localized Therapeutic Proteins

Preparation and Properties of an Injectable Thermo-Sensitive Double Crosslinking Hydrogel Based on Thiolated Chitosan/Beta-Glycerophosphate

Injectable enzymatically crosslinked hydrogels based on a poly(L-glutamic acid) graft copolymer

Injectable Polyphosphazene/gelatin Hybrid Hydrogel for Biomedical Applications

Controlled Gelation and Degradation Rates of Injectable Hyaluronic Acid-Based Hydrogels Through A Double Crosslinking Strategy

A PH/THERMO-RESPONSIVE INJECTABLE HYDROGEL SYSTEM BASED ON POLY(N-ACRYLOYLGLYCINE) AS A DRUG CARRIER

Rapidly in Situ Forming Polyphosphoester-Based Hydrogels for Injectable Drug Delivery Carriers

Injectable Supramolecular Hydrogels Based on Host–guest Interactions with Cell Encapsulation Capabilities

In Situ Injectable Poly(-Glutamic Acid) Based Biohydrogel Formed By Enzymatic Crosslinking

Preparation of a Novel Injectable in Situ-Gelling Nanoparticle with Applications in Controlled Protein Release and Cancer Cell Entrapment

Injectable in situ forming poly(l-glutamic acid) hydrogels for cartilage tissue engineering.